Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

LOPINAVIR AND RITONAVIR

LOPINAVIR; RITONAVIR

Standard Dose
80MG/ML;20MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview LOPINAVIR AND RITONAVIR is listed in Drugs@FDA under application 207407 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient LOPINAVIR; RITONAVIR Form and strength SOLUTION;ORAL - 80MG/ML;20MG/ML Sponsor LANNETT CO INC Submission history Latest submission status date: 2020-04-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview LOPINAVIR AND RITONAVIR is listed in Drugs@FDA under application 207407 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LOPINAVIR; RITONAVIR Form and strength SOLUTION;ORAL - 80MG/ML;20MG/ML Sponsor LANNETT CO INC Submission history Latest submission status date: 2020-04-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.